Some good views here. It appears to be changing from an undervalued asset situation to an earnings story. It is interesting that Temozolomide in their numbers which should add $15m to EBITDA in time. (refer Morgans report).
Looking for good news flow over the next 18 months.
Some good views here. It appears to be changing from an...
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.13M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $2.751K | 25.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 72418 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 19572 | 1 |
View Market Depth
| Last trade - 15.42pm 15/11/2024 (20 minute delay) ? |
| IDT (ASX) Chart |